Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Rang in aandelen #84
Abbott Laboratories, together with its subsidiaries, discovers, develops,... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Aandeelprijs
$101.91
Marktkapitalisatie
$177.09B
Verandering (1 dag)
-1.97%
Verandering (1 jaar)
-19.78%
Land
US
Handel Abbott Laboratories (ABT)

Categorie

Winst voor Abbott Laboratories (ABT)
Winst in Dec 2025 TTM: $8.47B
Volgens de meest recente financiële verslagen van Abbott Laboratories bedraagt de huidige winst van het bedrijf $8.47B. In 2024 behaalde het bedrijf een winst van $7.01B, een stijging ten opzichte van de winst van 2023, die $6.66B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Abbott Laboratories van 2000 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $8.47B 0.00%
2025 $8.47B 20.72%
2024 $7.01B 5.24%
2023 $6.66B -19.77%
2022 $8.31B 1.16%
2021 $8.21B 65.28%
2020 $4.97B 21.85%
2019 $4.08B 41.91%
2018 $2.87B 28.78%
2017 $2.23B 57.89%
2016 $1.41B -55.61%
2015 $3.18B 26.41%
2014 $2.52B -0.12%
2013 $2.52B -59.75%
2012 $6.26B 20.47%
2011 $5.20B -9.00%
2010 $5.71B -20.59%
2009 $7.19B 22.84%
2008 $5.86B 31.02%
2007 $4.47B 96.35%
2006 $2.28B -50.73%
2005 $4.62B 11.98%
2004 $4.13B 10.48%
2003 $3.73B 1.66%
2002 $3.67B 95.07%
2001 $1.88B -50.66%
2000 $3.82B 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$4.51B -46.68%
US
$5.56B -34.27%
IE
$5.56B -34.29%
IE
$3.39B -60.02%
US
$3.13B -63.01%
DE